Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2023 is 636.36% vs 67.39% in Sep 2022
Consolidate Net Profit
YoY Growth in quarter ended Sep 2023 is 139.46% vs -108.58% in Sep 2022
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2023 is 134.29% vs -127.81% in Sep 2022
Interest
YoY Growth in quarter ended Sep 2023 is 300.00% vs -67.86% in Sep 2022
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2023 has improved from Sep 2022
Compare Quarterly Results Of ImmunoGen, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2023 is 36.30% vs 66.73% in Jun 2023
YoY Growth in quarter ended Sep 2023 is 636.36% vs 67.39% in Sep 2022
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2023 is 830.95% vs 89.76% in Jun 2023
YoY Growth in quarter ended Sep 2023 is 139.46% vs -108.58% in Sep 2022
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2023 is 794.74% vs 90.93% in Jun 2023
YoY Growth in quarter ended Sep 2023 is 134.29% vs -127.81% in Sep 2022
Quarterly - Interest
QoQ Growth in quarter ended Sep 2023 is -18.18% vs 388.89% in Jun 2023
YoY Growth in quarter ended Sep 2023 is 300.00% vs -67.86% in Sep 2022
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2023 has improved from Jun 2023
YoY Growth in quarter ended Sep 2023 has improved from Sep 2022






